Piper Jaffray Cuts Price Target on Genomic Health (GHDX) After 4Q Reports In-Line with Preliminary Results

Go back to Piper Jaffray Cuts Price Target on Genomic Health (GHDX) After 4Q Reports In-Line with Preliminary Results

Jefferies Raises price Target on Genomic Health (GHDX) Following Initial 2016 Outlook

February 11, 2016 10:05 AM EST

Jefferies reiterated a Hold rating on Genomic Health Inc. (NASDAQ: GHDX), and raised the price target to $25.00 (from $24.00). Consistent with commentary last month, GHDX reiterated its 2016 revenue outlook ($328M mid-pt), which implies a sharp growth acceleration on the back of full-year contributions from recent... More

Genomic Health (GHDX) Misses Q4 EPS by 1c

February 10, 2016 4:39 PM EST

Genomic Health (NASDAQ: GHDX) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $74.5 million versus the consensus estimate of $74.03 million.

GUIDANCE:

Genomic Health sees FY2016 revenue of $320-335 million, versus the consensus of... More

Trading Radar for 2/10: Twitter (TWTR), Time Warner (TWX), Tesla (TSLA), Cisco (CSCO), Humana (HUM) Report

February 9, 2016 3:13 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
7:00am EST

MBA Mortgage Index - no Street consensus

Earnings:

ACCO Brands Corporation (Nasdaq: ACCO) - consensus EPS $0.28
ARM Holdings plc (Nasdaq: ARMH) - consensus EPS $0.38
AmTrust Financial (Nasdaq: AFSI) - consensus EPS $0.67
Aramark Services (Nasdaq: ARMK) - consensus EPS $0.49
Axalta Coating Systems (Nasdaq:... More